In:
Molecular Oncology, Wiley, Vol. 8, No. 8 ( 2014-12), p. 1495-1507
Abstract:
We report that the TPM3‐NTRK1 rearrangement is a low‐frequency recurring event in CRC. A validated IHC method for the identification of TRKA‐positive patients is provided. Pharmacological inhibition of TRKA is proposed as a novel therapeutic strategy for CRC.
Type of Medium:
Online Resource
ISSN:
1574-7891
,
1878-0261
DOI:
10.1016/j.molonc.2014.06.001
Language:
English
Publisher:
Wiley
Publication Date:
2014
detail.hit.zdb_id:
2322586-5
Permalink